 | Up a level |
Mathew, A J; Lund, M L; Pedersen, M P; Rasmussen, S H; Glintborg, B; Loft, A G; Nissen, M J; Möller, B; Rodrigues, A M; Santos, F P; Rotar, Z; Tomšič, M; Relas, H; Peltomaa, R; Gudbjornsson, B; Löve, T J; Kocaer, S B; Koken Avsar, A; Midtbøll Ørnbjerg, L and Østergaard, M (2024). Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response. Scandinavian journal of rheumatology, 53(4), pp. 237-247. Informa Healthcare 10.1080/03009742.2024.2336743
Leung, Ying-Ying; Korotaeva, Tatiana V; Candia, Liliana; Pedersen, Susanne Juhl; Bautista Molano, Wilson; Ruderman, Eric M; Bisoendia, Radjesh; Perez-Alamino, Rodolfo; Olsder, Wendy; Möller, B; Grazio, Simeon; Gudu, Tania; Mody, Girish M; Pineda, Carlos; Raffayova, Helena; Rohekar, Sherry; Goldenstein-Schainberg, Claudia; Gutierrez Urena, Sergio R; Casasola Vargas, Julio César; Meghnathi, Bhowmik; ... (2023). Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The journal of rheumatology, 50(1), pp. 119-130. The Journal of Rheumatology Publishing Company Limited 10.3899/jrheum.220315
Lüttgenau, J; Möller, B; Kradolfer, D; Wellnitz, Olga; Bruckmaier, Rupert; Miyamoto, A; Ulbrich, S E; Bollwein, H (2016). Lipopolysaccharide enhances apoptosis of corpus luteum in isolated perfused bovine ovaries in vitro. Reproduction, 151(1), pp. 17-28. BioScientifica 10.1530/REP-15-0281
Möller, B; Boller, C (2012). Neue Klassifikationskriterien für Frühdiagnostik und Frühtherapie der rheumatoiden Arthritis. Rheuma Schweiz(12) Zürich: Rheuma Schweiz
Seitz, M; Reichenbach, S; Möller, B; Zwahlen, M; Villiger, PM; Dufour, Jean-François (2010). Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study. Annals of the rheumatic diseases, 69(6), pp. 1148-1150. London: BMJ Publishing Group 10.1136/ard.2009.116194
Schmid, L; Müller, M; Treumann, T; Arnold, W; Möller, B; Aeberli, D; Villiger, P M (2009). Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis & rheumatism, 60(6), pp. 1632-4. Hoboken, N.J.: Wiley-Blackwell 10.1002/art.24577
Finckh, A; Ciurea, A; Burlhart, L; Möller, B; Walker, UA; Courvoisier, D; Kyburz, D; Dudler, J; Gabay, C (2009). Which Subgroup of Rheumatoid Arthritis Patients Benefits Most From Swichting to Rituximab Versus Alternative Anti-TNF Agenst After Previous Failure To Anit-TNF Agent? Annals of the rheumatic diseases, 69(2), pp. 387-393. London: BMJ Publishing Group 10.1136/ard.2008.105064
Möller, B; Aeberli, D; Eggli, S; Fuhrer, M; Vajtai, I; Vöglin, E; Ziswiler, HR; Dahinden, CA; Villiger, PM (2009). Class-switzched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis. Arthritis research & therapy, 11(3), R62. London: BioMed Central 10.1186/ar2686
Förger, F; Marcoli, N; Gadola, S; Möller, B; Villiger, P M; Østensen, M (2008). Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis. Annals of the rheumatic diseases, 67(7), pp. 984-90. London: BMJ Publishing Group 10.1136/ard.2007.075283
Turan, B; Pfister, K; Diener, P-A; Hell, M; Möller, B; Boyvat, A; Ergin, S; Villiger, P M (2008). Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease. Scandinavian journal of rheumatology, 37(2), pp. 135-41. Stockholm: Informa Healthcare 10.1080/03009740701747137
Seitz, M; Wirthmüller, U; Möller, B; Villiger, P M (2007). The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology, 46(1), pp. 93-6. Oxford: Oxford University Press 10.1093/rheumatology/kel175
Förger F.Marcoli, N; Gadola, S; Möller, B; Villiger, PM; Oestensen, M (2007). Pregnancy induces numerical and functional changes of CD4+CD25high regulatory T cells in patients with reumatoid arthritis. Annals of the rheumatic diseases(30), pp. 2-3. London: BMJ Publishing Group
Arntd, U; Behrens, F; Ziswiler, HR; Kaltwasser, JP; Möller, B (2007). Oberservational study of a patient and doctor directed pre-referral questionnarie for an early arthritis clinic. Rheumatology international, 28(1), pp. 21-26. Berlin: Springer-Verlag 10.1007/s00296-007-0382-x
Möller, B; Kerschbaumer, G; Komor, M; Kreschbaumer, F; Ottmann, OG; Hoelzer, D; Hofmann, WK (2007). Genomic imprinting of insulin-like growth factor 2 (IGF-2) in chronic synovitis. Growth hormone & IGF research, -17(6), pp. 500-5. Oxford: Elsevier 10.1016/j.ghir.2007.05.003
Finckh, A; Ciurea, A; Brulhart, L; Kyburz, D; Möller, B; Dehler, S; Reveaz, S; Dudler, J; Gabay, C (2007). B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Arthritis & rheumatism, -56(5), pp. 1417-23. Hoboken, N.J.: Wiley-Blackwell 10.1002/art.22520
Behrens, F; Himsel, A; Rehart, S; Stanczyk, J; Beutel, B; Zimmermann, SY; Koehl, U; Möller, B; Gay, S; Kaltwasser, JP; Pfeilschifter, JM; Radeke, HH (2007). Imbalance in distribution of functional autologous regulatroy T cells in rheumatoid arthritis. Annals of the rheumatic diseases, -66(9), pp. 1151-6. London: BMJ Publishing Group 10.1136/ard.2006.068320
